Earnings call transcript: Bayer Q3 2026 misses EPS but lifts outlook
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- BAYRY Bayer (ETR: BAYN)
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies. Linked by “sector of BAYRY” in this story
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BAYRYNon-US listing (OTC); price checks may stay empty | — | — | — | — | — | — | — |
| XLV | -2.95% | -0.31% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Earnings call transcript: Bayer Q3 2026 misses EPS but lifts outlook Investing.com
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
This story
12 out of 100
“Earnings call transcript: Bayer Q3 2026 misses EPS but lifts outlook” scores 12 out of 100. The score uses 1 sources.